Int J Pharm Pract 2002:3:11-16
School of Pharmacy and Pharmaceutical Sciences,
University of Manchester, Oxford Road, Manchester, England M13 9PL
Ellen I. Schafheutle, PhD, MRPharmS, research
associate
Karen Hassell, PhD, senior research fellow
Elizabeth M. Seston, MA Econ, research associate
Peter R. Noyce, PhD, FRPharmS, professor of pharmacy
practice
Correspondence:
Dr Schafheutle
Ellen.Schafheutle@man.ac.uk
|
Original Papers
Non-dispensing of NHS prescriptions in community pharmacies
Ellen I. Schafheutle, Karen Hassell, Elizabeth M. Seston and Peter R.
Noyce
Objective To explore
non-dispensing of National Health Service (NHS) prescriptions in community
pharmacies
Method Prospective study
on prescription items that were presented and not dispensed. Pharmacy staff
recorded reasons for non-dispensing of NHS prescription items and process
outcomes, including substitution through other means
Setting Sixteen community
pharmacies in the North of England
Key findings Data are
available on 587 items (514 patients). Two main reasons for non-dispensing
were identified: those related to the cost of the prescription charge (n=308)
and those unrelated to cost (n=279). The latter generally suggested a prescribing
issue involving the general practitioner's (GP's) computer system. Cost-related
reasons included cheaper availability of over-the-counter (OTC) products
(78.6 per cent) and incidents where customers were unwilling or unable to
pay the prescription charge (20.1 per cent). Unsurprisingly, cost-related
reasons were encountered almost exclusively for patients who were non-exempt
from prescription charges, while non-cost reasons were more commonly seen
for exempt patients. As a result of non-dispensing because of cost, 242
OTC products were sold, 97.0 per cent of which contained the same active
ingredient as had been prescribed by the doctor. There were 62 incidents
where a prescribed item was not dispensed, or substituted, because of cost,
and more than one-third of these items (n=22) could be considered to be
clinically important
Conclusion In addition
to issues of GP prescribing, the cost of the prescription charge was identified
as a major factor in non-dispensing. Many of the items were substituted
by cheaper OTC products, yet some clinically important drugs were not dispensed
or substituted, suggesting that a review of the UK charge system is appropriate
|